Volume 2, Issue 1 (7-2004)                   IJRM 2004, 2(1): 12-0 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sheikholslami B, Salehnia M, Rezazadeh M. The Effect of Different Concentrations of GM-CSF on the Development of Pre-Implantation Embryos in Mice (Pilot Study). IJRM. 2004; 2 (1) :12-0
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-12-en.html
Full-Text [PDF 30 kb]   (214 Downloads)     |   Abstract (HTML)  (765 Views)
Full-Text:   (9 Views)
    The GM-CSF is a glycoprotein with 23- kDa molecular weight and has some effects on immune and non-immune cells (Ruef and Coleman, 1990). This cytokine was produce by several cells in extramedullary sites such as mesangial cells (Budde et al., 1989), osteoblast (Horowitz et al., 1989), tracheal epithelial cells (Smith et al., 1990), and keratinocytes (Chodakewitz et al., 1988). It is also synthesized in the female reproductive tract and its targets in this site are myeloid leukocytes, preimplantation embryos and trophoblast cells (Robertson and Seamark, 1992; Chegini et al., 1999). Steroid hormones such as estrogen and progesterone affect the secretion of GM-CSF in the uterus (Robertson et al., 1996).
    Several investigators showed that GM-CSF has embryotrophic effect in mammals (Moraes and Hansen 1997; Sjoblom et al., 1999; Robertson et al. 2001). Moraes and Hansen (1997) indicated that GM-CSF may play a role in the early development of bovine embryos and might be useful for incrasing blastocyst production rates in serum free culture media.
    Robertsone et al. (1999) showed that fetal growth and viability were jeopardized in the absence of maternal GM-CSF, suggesting that GM-CSF of either maternal or fetal origin is required for optimal growth and survival of the fetus in mice.
    To examine the optimal dosage of GM-CSF for improving the development of mouse embryo, we examined its different concentrations (0, 2, and 10 ng /ml) in 2 cells and eight cells mouse embryo culture media. The developmental rates of those embryos were assesed and compared to hatching blastocysts.

Materials and Methods

    For embryo collection, superovulation of NMRI mice (6-10 weeks old) were performed using 10 IU injection of pregnant Mare Serum Gonadotropin (PMSG) followed with another injections of 10 IU Human Chorionic Gonadotropin (hCG) hormone 48 hours later. Following hCG injection, one or two females were caged with male mouse (8-10 weeks old). Female mice were examined for the vaginal plug on the following morning and the presence of vaginal plug was considered as pregnancy. To collect two cells and eight cells embryos, the pregnant females were sacrificed by cervical dislocation at 48 h and 72 h post hCG injections, respectively. The collected embryos at two and eight cells developmental stages were cultured randomly in T6 medium supplemented with 5 mg /ml BSA and 0, 2, and 10 ng / ml concentrations of rGM-CSF. The developmental rates of embryos were assessed daily under inverted microscope until 120 h (for 2 cells embryos) and 96 h (for 8 cells embryos) after culturing to hatching blastocyst stage. The data of blastocyst formation and blastocyct hatching in different groups of embryo culture were compared by chi-square analysis.

    The development of two cells and eight cells embryos in the presence of different concentrations of recombinant GM-CSF at four repeat experiences are presented in the table I. From the total of 42, 38 and 41 two cells embryos which were cultured in the medium containing 0, 2, and 10 ng/ ml GM-CSF, 5 (11.9%), 4 (15.2%) and 6 (12%) reached to murolla, 8 (19.4%), 7(18.3%) and 8 (20%) reached to blastocyst stage and 15 (37.8%), 18 (51.5%) and 13 (31.8%) reached to hatched blastocyst stage at 120 h after culturing, respectively. The degenerated embryos in those groups were 14 (33.3%), 9 (23.7%) and 14 (34.1%), respectively.
    From the total of 35, 29 and 32 eight cells embryos, which were cultured in the different concentrations of GM-CSF (0, 2, and 10 ng/ml), 6 (17.1%), 3 (10.3%) and 5 (15.6%) reached to murolla and 10 (28.5%), 6 (20.7%) and 9 (28.1%) reached to blastocyst stage and 10 (28.5%), 14 (49.7%) and 10 (31.2%) reached to hatched blastocyst stage, respectively. The degenerated embryos in those groups were 9 (25.7%), 6 (20.7%) and 8 (25.7%), respectively. However, the developmental rates of embryos in the presence of 2 ng/ml of GM-CSF were higher than the other groups, but insignificant between the experimental groups and their controls.          
    The data of the present study showed that the GM-CSF is one of the cytokine that increases the embryo development in  mice. It   has  the  greatest  effect   to enhance the hatching rate of embryos on both 2 cells and 8 cells stages at 2 ng /ml concentration. The hatching rate of 2 cells embryos was 51.5% and for 8 cells embryos was 49.7%. However, in this regards in comparison with the other groups there were not significantly differences. Also, after 120 h of culturing the number of degenerated embryos at 2 ng /ml concentration of GM-CSF was lower than the other groups (23.7% V.S. 33.3% and 34.1% for 2 cell embryos, also 20.7% V.S. 25.7% and 25.7% for 8 cell embryos). Further study is needed on the larger number of embryos to confirm these differences.
      Thus, it seems that the GM-CSF with 2 ng/ml concentration has better potential not only to enhance the developmental rates of 2 cells and 8 cells embryos, but also for decreasing the degeneration of those embryos. Finally, because this research was only a pilot study, more researches are necessary to confirm our findings.
     It has been shown that GM-CSF is a physiologically important regulator of embryonic development in vivo and it present in the uterus as a product of the maternal tissue or embryo (Chegini et al., 1999; Moraes et al., 1999). After mating in mice, the GM-CSF concentration in uterus was increased ( Semark and Robertson 1990; Robertson et al., 1992). It is possible that activation of specific lymphoid cell populations in the uterus by serum or conceptus antigens could increase GM-CSF production (Jokhi et al., 1994). More studies should be performed to evaluate the effects of GM-CSF on the embryo quality and pregnancy rates.
Type of Study: Original Article |

1. Budde K., Coleman D.L., Lacy J., and Sterzel R.B. (1989) Cultured rat mesengial cells produce granulocyte macrophage -colony stimulating factor. Am J Physiol 257: 1065-1078. [DOI:10.1152/ajprenal.1989.257.6.F1065] [PMID]
2. Chegini N., Tang XM., and Dou Q. (1999) The expression, activity and regulation of granulocyte macrophage -colony stimulating factor in human endometrial epithelial and stromal cells. Mol Hum Reprod 5: 454-466. [DOI:10.1093/molehr/5.5.459] [PMID]
3. Chodakewitz J.A., Kupper T.S., and Coleman DL. (1988) Keratinocyte-derived granulocyte macrophage -colony stimulating factor induces DNA synthesis by peritoneal macrophages. J Immunol 140: 832-836.
4. Horowitz M.C., Colman D.L., Flood P.M., Kupper T.S., and Jilka R. (1989) Parathroid hormone and lipopolysacaride induce murine osteoblast- like cells to secrete a ctokine indistingushable from granulocyte macrophage -colony stimulating factor. J Clin Invest 83: 149-157. [DOI:10.1172/JCI113852] [PMID] [PMCID]
5. Jokhi P.P., King A., and Loke Y.W. (1994) Production of granulocyte macrophage -colony stimulating factor by human triphoblast cells and by decidual large lymphocytes. Hum Reprod 9: 1660-1669. [DOI:10.1093/oxfordjournals.humrep.a138769] [PMID]
6. Moraes A.A., and Hansen P.J. (1997) Granulocyte macrophage - colony stimulating factor promotes development of in vitro produced bovine embryos. Biol Reprod 57: 1060-1065. [DOI:10.1095/biolreprod57.5.1060] [PMID]
7. Moraes A.S., Paula-Lopes F.F., Chegini N., and Hansen P.J. (1999) Localization of granulocyte macrophage -colony stimulating factor in the bovine reproductive tract. Reprod Immunol 42: 135-145. [DOI:10.1016/S0165-0378(98)00075-8]
8. Robertson S.A., and Seamark R.F. (1992) Granulocyte-macrophage colony stimulating factor (GM-CSF): One of a family of epithelial cell-derived cytokines in the preimplantation uterus. Reprod Fertil Dev 4: 435-448. [DOI:10.1071/RD9920435] [PMID]
9. Robertson S.A., Mayrhofer G., and Semark R.F. (1992) Uterine epithelial cells synthesize granulocyte macrophage -colony stimulating factor and interleukine-6 in pregnant and non pregnant mice. Biol Reprod 46: 1069-1079. [DOI:10.1095/biolreprod46.6.1069] [PMID]
10. Robertson S.A., Mayrhofer G., and Semark R.F. (1996) Ovarian steroid hormones regulate granulocyte macrophage -colony stimulating factor synthesis by uterine epithelial cells in the mouse. Biol Reprod 54: 183-196. [DOI:10.1095/biolreprod54.1.183] [PMID]
11. Robertson S.A., Roberts C.T., Farr K.L., Dunn A.R., and Seamark R.F. (1999) Fertility impairment in granulocyte macrophage -colony stimulating factor- deficient mice. Biol Reprod 60: 251-261. [DOI:10.1095/biolreprod60.2.251] [PMID]
12. Robertson S.A., Sjoblom C., Jasper M.L., Norman R.J., and Seamark R.F. (2001) Ganulocyte macrophage -colony stimulating factor promotes glucose transport and blastomere viability in murine preimplantation embryos. Biol Reprod 64: 1206-1215. [DOI:10.1095/biolreprod64.4.1206] [PMID]
13. Ruef C., and Coleman D.L. (1990) Granulocyte macrophage -colony stimulating factor: Pleiotrophic cytokine with potential clinical usefulness. Rev Infect Dis 12: 41-62. [DOI:10.1093/clinids/12.1.41] [PMID]
14. Seamark R.F., and Robertson S.A. (1990) Granulocyte macrophage -colony stimulating factor (GM-CSF) in murine reproductive tract: stimulation by seminal factors. Reprod Fertil Dev 2: 359-368. [DOI:10.1071/RD9900359] [PMID]
15. Sjoblom C., Wikland M., and Robertson S.A. (1999) Granulocyte-macrophage colony-stimulating factor promotes human blastocyst development in vitro. Hum Reprod 14(12): 3069-3076. [DOI:10.1093/humrep/14.12.3069] [PMID]
16. Smith S.M., Lee D.K.P., Lacy J., and Colman D.L. (1990) Rat tracheal epithelial cell produce granulocyte macrophage -colony stimulating factor. Am J Respiratory Cell Mol Biol 2: 59-68. [DOI:10.1165/ajrcmb/2.1.59] [PMID]

Add your comments about this article : Your username or Email:

© 2020 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb